ZURICH, March 19, 2025 – ArisGlobal, a prominent technology provider for the life sciences sector and the creator of LifeSphere®, introduced three new product offerings at its annual industry event, Breakthrough 2025. These advancements aim to significantly improve pharmacovigilance and regulatory operations.
New Product Highlights
ArisGlobal’s new offerings include:
-
LifeSphere Unify: A platform designed to integrate data and processes across safety, medical affairs, regulatory, and quality domains. It leverages NavaX to accelerate treatment time-to-market, promote data-driven decision-making, ensure interoperability, and provide seamless scalability and security.
-
NavaX Insights: A new capability leveraging Agentic AI to extract real-time, actionable insights from large and complex datasets. This tool is designed to identify emerging risks, uncover hidden patterns, and improve decision-making processes within pharmacovigilance and regulatory operations.
-
Advanced Compliance Docs: A cloud-based document management system, also powered by LifeSphere NavaX, that streamlines the creation, storage, and management of critical pharmacovigilance documents, including Pharmacovigilance System Master Files and aggregate reports. This feature is designed to automate document management, accelerate document retrieval and promote efficient collaboration.
“We’re thrilled to announce these new offerings as ArisGlobal continues to make investment in building the best applications leveraging the latest AI technology,” said Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal. “The LifeSphere Unify Platform offers unmatched value in data sharing and interoperability, empowering organizations to seamlessly connect insights across the entire ecosystem. With NavaX Insights we’re moving beyond automating processes for efficiency gains, enabling organizations with insights to make smarter, data-driven decisions faster than ever before. In a similar fashion, Advanced Compliance Docs is meeting the need for pharma re-evaluating their medical writing strategies to optimize costs and enhance efficiency.” ArisGlobal is committed to responsible AI adoption and has signed the EU AI Pact, reinforcing its commitment to ethical AI use. The company hosted Breakthrough 2025 in Zurich, Switzerland, where industry leaders and experts discussed “AI in Action” and its applications in life sciences.
For more information, visit https://www.arisglobal.com/breakthrough or follow ArisGlobal on LinkedIn.
